These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37932183)

  • 1. Function of gamma delta (γδ) T cell in cancer with special emphasis on cervical cancer.
    Patra S; Ghosal S; Shand H; Mondal R; Rath A; Kumar Jana S; Ghorai S
    Hum Immunol; 2023 Dec; 84(12):110724. PubMed ID: 37932183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer.
    Li J; Cao Y; Liu Y; Yu L; Zhang Z; Wang X; Bai H; Zhang Y; Liu S; Gao M; Lu C; Li C; Guan Y; Tao Z; Wu Z; Chen J; Yuan Z
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex Vivo Expanded Human Vγ9Vδ2 T-Cells Can Suppress Epithelial Ovarian Cancer Cell Growth.
    Mao TL; Miao CH; Liao YJ; Chen YJ; Yeh CY; Liu CL
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunotherapy with γδ T cells: many paths ahead of us.
    Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
    Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. γδ T cells and their potential for immunotherapy.
    Wu YL; Ding YP; Tanaka Y; Shen LW; Wei CH; Minato N; Zhang W
    Int J Biol Sci; 2014; 10(2):119-35. PubMed ID: 24520210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-Presenting Cell Characteristics of Human γδ T Lymphocytes in Chronic Myeloid Leukemia.
    Sawaisorn P; Tangchaikeeree T; Chan-On W; Leepiyasakulchai C; Udomsangpetch R; Hongeng S; Jangpatarapongsa K
    Immunol Invest; 2019 Jan; 48(1):11-26. PubMed ID: 30321079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gammadelta T cells for immune therapy of patients with lymphoid malignancies.
    Wilhelm M; Kunzmann V; Eckstein S; Reimer P; Weissinger F; Ruediger T; Tony HP
    Blood; 2003 Jul; 102(1):200-6. PubMed ID: 12623838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?
    Gougeon ML; Malkovsky M; Casetti R; Agrati C; Poccia F
    Vaccine; 2002 May; 20(15):1938-41. PubMed ID: 11983250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. γδ T cell-mediated cytotoxicity against patient-derived healthy and cancer cervical organoids.
    Dong J; Holthaus D; Peters C; Koster S; Ehsani M; Quevedo-Olmos A; Berger H; Zarobkiewicz M; Mangler M; Gurumurthy RK; Hedemann N; Chumduri C; Kabelitz D; Meyer TF
    Front Immunol; 2023; 14():1281646. PubMed ID: 38090581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate.
    Kato Y; Tanaka Y; Tanaka H; Yamashita S; Minato N
    J Immunol; 2003 Apr; 170(7):3608-13. PubMed ID: 12646624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
    Liu Y; Zhang C
    Cells; 2020 May; 9(5):. PubMed ID: 32413966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic function of gamma delta (gamma/delta) T cells against pamidronate-treated cervical cancer cells.
    Lertworapreecha M; Patumraj S; Niruthisard S; Hansasuta P; Bhattarakosol P
    Indian J Exp Biol; 2013 Aug; 51(8):597-605. PubMed ID: 24228383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ex vivo-expanded γδ-T cells combined with galectin-1 antibody on the growth of human cervical cancer xenografts in SCID mice.
    Li H; Wang Y; Zhou F
    Clin Invest Med; 2010 Oct; 33(5):E280-9. PubMed ID: 20926034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γδ T Cells in Tumor Microenvironment.
    Imbert C; Olive D
    Adv Exp Med Biol; 2020; 1273():91-104. PubMed ID: 33119877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future.
    Saura-Esteller J; de Jong M; King LA; Ensing E; Winograd B; de Gruijl TD; Parren PWHI; van der Vliet HJ
    Front Immunol; 2022; 13():915837. PubMed ID: 35784326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. γδ T Cell-Mediated Immune Responses in Disease and Therapy.
    Latha TS; Reddy MC; Durbaka PV; Rachamallu A; Pallu R; Lomada D
    Front Immunol; 2014; 5():571. PubMed ID: 25426120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of human peripheral blood γδ T cells using zoledronate.
    Kondo M; Izumi T; Fujieda N; Kondo A; Morishita T; Matsushita H; Kakimi K
    J Vis Exp; 2011 Sep; (55):. PubMed ID: 21931292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen.
    Miyagawa F; Tanaka Y; Yamashita S; Minato N
    J Immunol; 2001 May; 166(9):5508-14. PubMed ID: 11313389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro.
    Liu Z; Guo BL; Gehrs BC; Nan L; Lopez RD
    J Urol; 2005 May; 173(5):1552-6. PubMed ID: 15821484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.